cofosfolactamine
combination of above cpds
Also Known As:
cophospholactamine; moxiprim; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-, mixt. with (2R-cis)-(3-methyloxiranyl)phosphonic acid
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
for this Bio-Agent,
Comments
Bio-Agent Context: Research Results
Related Diseases
| 1. | Infection
06/01/1985
- "In the present multicenter, randomized and double-blind study, performed on 127 hospitalized patients, we compared the effects of three antibiotics (cephemic cofosfolactamine, cephalexin and fosfomycin) in the treatment of acute or recurrent systemic infections. "
06/01/1985 - "A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections." Order ALL the reference details at left... |
| 2. | Bacterial Infections (Bacterial Infection)
01/01/1984
- "[Use of cofosfolactamine in localized bacterial infections]"
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | Fosfomycin
|
| 2. | Cephalexin (Cefalexin)
|
| 3. | Anti-Bacterial Agents (Antibiotics)
|
TREATMENT OPTIONS
for Infection,
Ranking and Evidence
for Infection,
Ranking and Evidence
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
Analytic charts allow you and your physicians to see at a glance the
treatment options—including new, promising, off-label and experimental.
- Free Updates for 1 Year
- All 14522 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Evidence References
- Sample PDF Report on Psoriasis >>
| Price: | $8.50 USD
& Delivery via
PDF download
updates for 1 year |
Research Interface PRO
- Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
- Enable Experts: Quickly identify key researchers and their publications
- Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
- Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
- Research Network: Explore drug and disease relationships visually
- Enable Mobile Interface: Access from your cellphone, iPhone or PDA
| Price: | $45.00 USD
access via web interface 1 year subscription |